Advanced company searchLink opens in new window

QIAGEN HEALTHCARE BIOTECHNOLOGIES LIMITED

Company number 11561466

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
16 Oct 2024 AA Micro company accounts made up to 9 March 2024
15 Oct 2024 CS01 Confirmation statement made on 9 September 2024 with no updates
06 Dec 2023 AA Micro company accounts made up to 9 March 2023
17 Oct 2023 CS01 Confirmation statement made on 9 September 2023 with no updates
30 Nov 2022 DISS40 Compulsory strike-off action has been discontinued
29 Nov 2022 GAZ1 First Gazette notice for compulsory strike-off
25 Nov 2022 AA Unaudited abridged accounts made up to 9 March 2022
23 Nov 2022 CS01 Confirmation statement made on 9 September 2022 with no updates
11 May 2022 DISS40 Compulsory strike-off action has been discontinued
10 May 2022 GAZ1 First Gazette notice for compulsory strike-off
05 May 2022 AA Total exemption full accounts made up to 9 March 2021
02 Feb 2022 TM01 Termination of appointment of Peer Michael Shatz as a director on 2 February 2022
06 Dec 2021 CS01 Confirmation statement made on 9 September 2021 with updates
19 Nov 2021 AD01 Registered office address changed from , Citylabs 2.0 Hathersage Road, Manchester, M13 0JH, England to Citylabs 2.0 Hathersage Road Manchester M13 0BH on 19 November 2021
28 Sep 2021 AD01 Registered office address changed from , Skelton House Lloyd Street North, Manchester, M15 6SH, United Kingdom to Citylabs 2.0 Hathersage Road Manchester M13 0BH on 28 September 2021
26 Apr 2021 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 09/03/20
25 Nov 2020 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 09/03/20
18 Nov 2020 AA Total exemption full accounts made up to 9 March 2020
22 Sep 2020 CS01 Confirmation statement made on 9 September 2020 with no updates
18 Aug 2020 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 09/03/20
26 Nov 2019 AA01 Current accounting period extended from 30 September 2019 to 9 March 2020
20 Sep 2019 CS01 Confirmation statement made on 9 September 2019 with updates
20 Sep 2019 CH01 Director's details changed for Peer Michael Shatz on 30 August 2019
09 Sep 2019 AP01 Appointment of Richard Powell Price as a director on 30 August 2019
06 Sep 2019 PSC02 Notification of Qiagen N.V. as a person with significant control on 30 August 2019